MIAMI, FL (August 21, 2024) – Lavior Pharma Inc., an International advanced diabetic wound and skincare Company headquartered in Miami, Florida, announced the appointment of Vladimir Urbin, MD to the Company’s Scientific Executive Advisory Board. Dr. Urbin is a renowned physician dedicated to wound healing and burn care. His commitment to excellence is evident in his numerous certifications, including ACLS, ATLS, and board certifications in Wound Management and Wound Healing. His active participation in professional organizations like the American Medical Association and the American Burn Association demonstrates his dedication to advancing the field. Throughout his career, Dr. Urbin has held prestigious positions, including Fellow at Stroger Hospital, Staff Resource Physician at Weiss Memorial Hospital, and currently serving as Wound and Burn Physician and CEO at North Shore Wound Center and Integrative Wellness Clinic. His leadership extends beyond his own practice, as he also serves as Medical Director of Wound Services at Kindred Hospitals and Medical Director of Clinical Operations at Vax Concierge. Additionally, he is affiliated with Thorek Memorial Hospital and West Suburban Hospital in Chicago.

“We are thrilled to welcome Dr. Vladimir Urbin to our scientific advisory board. His extensive expertise in wound healing and burn care will undoubtedly provide valuable insights and guidance as we continue to advance our research and develop innovative solutions” says Gilad Savion, the CEO and President of Lavior.

About Lavior Pharma Inc.

LAVIOR is the only company exclusively dedicated to the therapeutic diabetes skin care market.  The LAVIOR skincare product line soothes and heals some of the most widespread and challenging skin problems – diabetic ulcers, wounds, burns, eczema/atopic dermatitis, bacterial and fungal infections, skin irritations, and cracked skin. LAVIOR’s line of products is based on the proven efficacy of the Inula AGS RIED botanical species. They are developed using the highest quality, pharmaceutical grade ingredients; manufactured and tested to deliver safe, effective, and compliant products. Backed by over 13 years of extensive research and clinical trials, proven clinical safety and efficacy, they consistently outperform conventional treatments.

For more information on Lavior Pharma and its products, please visit www.lavior.com

For Media or other Inquiries, please contact:

Anabelle Savion
Managing Director
Phone: (+1) 9178373355
anabelle@lavior.com